Stay updated with breaking news from Cseries Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufacturing
Halfwheel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from halfwheel.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, announced today the Journal of Clinical Oncology published...
WLRN News took home 14 wins and four finalist honors in the statewide Florida Association of Broadcast Journalists awards for journalism produced in 2022.
Domvanalimab-containing treatment regimens may improve outcomes, when compared with zimberelimab alone, in patients with PD-L1-high NSCLC.